Symbols

AVNS

Avanos Medical·NYSE

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 1

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About AVNS

Avanos Medical, Inc.

A clinical medical devices manufacturer that provides solutions in more than 90 countries

Industry

Healthcare Equipment and Supplies

Established Date

02/25/2014

Listing Date

10/21/2014

Exchange

New York Stock Exchange

Full-time Employees

2,287

Fiscal Year Ends

12-31

Website

www.avanos.com

Security Type

Common stock

Office address

5405 Windward Parkway, Suite 100 South , Alpharetta, GA 30004

Business

Introduction

Avanos Medical, Inc., was originally incorporated in Delaware on February 25, 2014. The company is a medical technology company focused on providing clinically superior medical device solutions that help patients get back to what matters. The company is committed to meeting some of the most important healthcare needs today, including providing a vital nutritional lifeline for patients from the hospital to their homes, reducing opioid use, and helping patients transition from surgery to recovery. The company develops, manufactures and markets its recognized brands globally and holds leading market positions in several categories of its portfolio.

Company Financials

EPS

AVNS has released its 2025 Q4 earnings. EPS was reported at 0.29, versus the expected 0.25, beating expectations. The chart below visualizes how AVNS has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

AVNS has released its 2025 Q4 earnings report, with revenue of 180.90M, reflecting a YoY change of 0.72%, and net profit of -1.30M, showing a YoY change of 99.67%. The Sankey diagram below clearly presents AVNS's revenue sources and cost distribution.